1. Attaluri A, Donahoe R, Valestin J, BrownK, Rao S. Randomized clinical trial: driedplums (prunes) vs. psyllium for constipa-tion. Aliment Pharmacol Ther 2011; 33:822–8.2. Bolin T. IBS or intolerance? Aust FamPhysician 2009; 38: 962–5.3. Hyams J. Sorbitol intolerance: an unap-preciated cause of functional gastrointesti-nal complaints. Gastroenterology 1983;84: 30–3.4. McRorie J, Zorich N, Riccardi K, et al.Effects of olestra and sorbitol consump-tion on objective measures of diarrhea:impact of stool viscosity on common gas-trointestinal symptoms. Regul ToxicolPharmacol 2000; 31: 59–67.5. Greave R, Broen R, Farthing M. An airstewardess with puzzling diarrhoea. Lancet1996; 348: 1488.6. McRorie J, Daggy B, Morel J, Diersing P,Miner P, Robinson M. Psyllium is supe-rior to docusate sodium for treatment ofchronic constipation. Aliment PharmacolTher 1998; 12: 491–7.7. Eherer A, Santa Ana C, Fordtran J. Effectof psyllium, calcium polycarbophil, andwheat bran on secretory diarrhea inducedby phenolphthalein. Gastroenterology1993; 104: 1007–12.8. Washington N, Harris M, Mussellwhite A,Spiller R. Moderation of lactulose-induceddiarrhea by psyllium: effects on motilityand fermentation. Am J Clin Nutr 1998;67: 317–21.9. Singh B. Psyllium as a therapeutic anddrug delivery agent. Int J Pharm 2007;334: 1–10.10. Bijkerk C, de Wit N, Muris J, WhorwellP, Knottnerus J, Hoes A. Soluble or insol-uble fibre in irritable bowel syndrome inprimary care? Randomised placebocontrolled trial. British Med J 2009; 339:b3154–60.
[1]
B. Pigneur,et al.
Tube feeding therapy in paediatric Crohn’s disease: authors’ reply
,
2011
.
[2]
O. Goulet,et al.
The efficacy of exclusive nutritional therapy in paediatric Crohn’s disease, comparing fractionated oral vs. continuous enteral feeding
,
2011,
Alimentary pharmacology & therapeutics.
[3]
G. Barbara,et al.
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof‐of‐concept study
,
2009,
Alimentary pharmacology & therapeutics.
[4]
T. Hausken,et al.
Development of functional gastrointestinal disorders after Giardia lamblia infection
,
2009,
BMC gastroenterology.
[5]
R. Spiller,et al.
Randomized, double‐blind, placebo‐controlled trial of prednisolone in post‐infectious irritable bowel syndrome
,
2003,
Alimentary pharmacology & therapeutics.